Drug manufacturer may be liable in Vegas hepatitis C outbreak
Infection Control Weekly Monitor, February 10, 2010
Want to receive articles like this one in your inbox? Subscribe to Infection Control Weekly Monitor!
A sworn deposition from a drug company executive may prove that the company that makes propofol used at the Las Vegas clinic is partially responsible for the hepatitis C outbreak in February 2008.
Attorneys who represent former patients of the Endoscopy Center of Southern Nevada have a deposition from Craig Lea, a marketing vice president at Teva Parenteral Medicines in Irvine, CA, that may hold the drug company at least partially liable.
For more on this development, visit OSHA Healthcare Advisor.
Want to receive articles like this one in your inbox? Subscribe to Infection Control Weekly Monitor!
Related Products
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- What does case-mix index mean to you?
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- HIPAA Q&A: Level of encryption needed for email
- Searched
